63 related articles for article (PubMed ID: 5454548)
1. [Changes in the hematopoietic system during treatment with 5-fluorouracil].
Voznyĭ EK
Vopr Onkol; 1970 Apr; 16(4):64-7. PubMed ID: 5454548
[No Abstract] [Full Text] [Related]
2. A clinical study of fluorouracil.
Nadler SH; Moore GE
Surg Gynecol Obstet; 1968 Dec; 127(6):1210-4. PubMed ID: 4882472
[No Abstract] [Full Text] [Related]
3. [The morphologic composition of peripheral blood following intra-arterial infusion of 5-fluorouracil and alkylating preparations in stomach cancer patients].
Chernyĭ VA
Vopr Onkol; 1970 Apr; 16(4):61-4. PubMed ID: 4989339
[No Abstract] [Full Text] [Related]
4. Correspondence re: Raida, M. et al., prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls.
Innocenti F; Ratain MJ
Clin Cancer Res; 2002 May; 8(5):1314; author reply 1315-6. PubMed ID: 12006555
[No Abstract] [Full Text] [Related]
5. Experience with ftorafur treatment in breast cancer.
Karev NI; Blokhina NG; Vozny EK; Pershin MP
Neoplasma; 1972; 19(4):347-50. PubMed ID: 5054534
[No Abstract] [Full Text] [Related]
6. Corticosteroids and fluorouracil toxicity.
Horton J; Olson KB; Hosley HF
Arch Intern Med; 1966 Jun; 117(6):775-7. PubMed ID: 5327216
[No Abstract] [Full Text] [Related]
7. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).
Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR
Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208
[No Abstract] [Full Text] [Related]
8. Phase II study of 5-fluorouracil and adriamycin in transitional cell carcinoma of the urinary tract.
Martino S; Samal B; Al-Sarraf M
Cancer Treat Rep; 1980 Jan; 64(1):161-3. PubMed ID: 7379051
[TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
10. A controlled evaluation of 5-fluorouracil utilizing a single injection technique.
Ahmann DL; Moertel CG; Bisel HF; Hahn RG; Schutt AJ; Dines DE
Oncology; 1974; 29(2):166-71. PubMed ID: 4836677
[No Abstract] [Full Text] [Related]
11. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.
Raida M; Schwabe W; Häusler P; Van Kuilenburg AB; Van Gennip AH; Behnke D; Höffken K
Clin Cancer Res; 2001 Sep; 7(9):2832-9. PubMed ID: 11555601
[TBL] [Abstract][Full Text] [Related]
12. 5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase II trial.
Havsteen H; Sörenson S; Rørth M; Dombernowsky P; Hansen HH
Cancer Treat Rep; 1981; 65(1-2):123-5. PubMed ID: 6261945
[TBL] [Abstract][Full Text] [Related]
13. [Low-dose FP therapy for advanced and recurrent gastric cancer].
Yamashita Y; Ohira M; Sowa M; Shirasaka T; Hirakawa K; Chung YS
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1548-53. PubMed ID: 10553411
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate and the platelet count.
Ogston D; Dawson AA; Philip JF
Br J Cancer; 1968 Jun; 22(2):244-9. PubMed ID: 5660130
[No Abstract] [Full Text] [Related]
15. Is toxicity really necessary? II. Source and analysis of data.
Bross ID; Rimm AA; Slack NH; Ausman RK; Jones R
Cancer; 1966 Dec; 19(12):1785-95. PubMed ID: 5927938
[No Abstract] [Full Text] [Related]
16. Cimetidine-associated thrombocytopenia and leukopenia.
Collen MJ
West J Med; 1980 Mar; 132(3):257-8. PubMed ID: 7053220
[No Abstract] [Full Text] [Related]
17. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
18. [On clinical use of high single doses of sarcolysine and exdoxan (cyclophosphan)].
Garin AM; Astrakhan VI; Bychkov MB; Larionov LF; Perevodchikova NI
Vopr Onkol; 1965; 11(10):3-9. PubMed ID: 5333877
[No Abstract] [Full Text] [Related]
19. Phase II study of VM-26 in adult malignancies.
Spremulli E; Schulz JJ; Speckhart VJ; Wampler GL
Cancer Treat Rep; 1980 Jan; 64(1):147-9. PubMed ID: 7379049
[No Abstract] [Full Text] [Related]
20. Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment.
Neijt JP; van Lindert AC; Vendrik CP; Roozendaal KJ; Struyvenberg A; Pinedo HM
Cancer Treat Rep; 1980; 64(2-3):323-6. PubMed ID: 6773656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]